Search

Your search keyword '"Rossi, G."' showing total 677 results

Search Constraints

Start Over You searched for: Author "Rossi, G." Remove constraint Author: "Rossi, G." Publisher elsevier bv Remove constraint Publisher: elsevier bv
677 results on '"Rossi, G."'

Search Results

3. OC.15.3: INCIDENCE AND CHARACTERISTICS OF ENDOSCOPIC GASTRIC POLYPS IN PATIENTS WITH AUTOIMMUNE ATROPHIC GASTRITIS: A MULTICENTRIC RETROSPECTIVE STUDY

5. BOC.04.3: PREDICTING THE NEED FOR STEP-UP AFTER EUS-GUIDED DRAINAGE OF PERIPANCREATIC FLUID COLLECTIONS, INCLUDING QNI SCORE VALIDATION: A PROSPECTIVE COHORT STUDY

6. OC.10.4: EUS-GUIDED DRAINAGE OF POST-SURGICAL VERSUS POSTPANCREATITIS COLLECTIONS (RESPELL): A PROSPECTIVE COMPARISON OF CLINICAL PRESENTATIONS AND THERAPEUTIC OUTCOMES

7. T.03.6: A BASAL-LIKE PANCREATIC CANCER MOLECULAR SUBTYPE CAN BE IDENTIFIED ON EUS-ACQUIRED TISSUE AND IS ASSOCIATED TO SMOKING, LOWER CA19.9 ANDWORSE PROGNOSIS

8. Open vs minimally invasive liver surgery for gallbladder cancer, an Italian registry-based analysis

9. 123P A phase II study of nivolumab (N) plus ipilimumab (I) and ASTX727 or N plus I in PD-1/PD-L1 resistant melanoma or NSCLC patients: The run-in phase of the NIBIT Foundation ML1 study

10. 113P A multidisciplinary management of immune-checkpoint inhibitor (ICI)-related pneumonitis to improve its clinical management

11. Tailoring allocation policies and improving access to pediatric liver transplantation over a 16-year period

12. PL03.07 Invasion or No Invasion, That’s the Question. A Large Reproducibility Study in Pulmonary Adenocarcinoma, Supporting a Modified Classification

13. P2.05-02 MAPK1/MAPK3 Mutations Enhance Immunotherapy Efficacy in Lung Squamous Cell Carcinoma (LSCC): Results of the SQUINT Trial

17. 66P Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)

18. Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy

19. Neutron irradiation of Hydrogenated Amorphous Silicon p-i-n diodes and charge selective contacts detectors

20. T.07.10 CONTINUOUS SMOKING MAY PLAY A ROLE IN THE PROGRESSION FROM “TRIVIAL” (THE GOOD) BD-IPMNS TO IPMNS WITH AN INDICATION FOR SURGERY (“THE BAD”) AND PANCREATIC CANCER (THE “UGLY”)

21. OC.09.4 THE IMPACT OF A MULTIDISCIPLINARY TEAM EVALUATION ON THE DIAGNOSIS AND MANAGEMENT OF ACUTE AND CHRONIC PANCREATITIS IN A TERTIARY REFERRAL CENTER

22. T.12.9 SAME-SESSION ENDOSCOPIC DIAGNOSIS AND SYMPTOMS' PALLIATION IN PANCREATOBILIARY MALIGNANCIES: CLINICAL IMPACT OF RAPID-ON-SITE EVALUATION

24. OC.09.5 ALTERNATION OF MRI AND EUS IN PANCREATIC CANCER SCREENING COULD INCREASE DETECTION OF BOTH PANCREATIC AND EXTRA-PANCREATIC FINDINGS

28. Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature

29. Continuous smoking may play a role in the progression from УtrivialФ (the good) BD-IPMNs to IPMNs with an indication for surgery (Уthe badФ) and Pancreatic Cancer (the УuglyФ).

33. 1048P Molecular predictors of immunotherapy efficacy in lung squamous-cell carcinoma (LSCC): Results from the randomized prospective SQUINT trial

34. EP08.01-030 Nivolumab+Ipilimumab Vs Platinum-Based CT+Nivolumab In Advanced Lung Squamous-Cell Carcinoma: The Randomized SQUINT Trial

35. EP08.01-088 Direct Acting Antivirals (DAA) and Immune Checkpoint Inhibitors (ICIs) Therapy in Patients with Lung Cancer and Hepatitis C

37. 1099P Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients

38. Facteurs histologiques associés à une complication hépatique au cours de la sarcoïdose hépatique : analyse descriptive anatomoclinique à partir d’une cohorte multicentrique de 92 patients

39. Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force

43. VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer

44. 90TiP Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6)

45. SARS-CoV-2 infection in liver transplantation is associated with favorable outcomes: an Italian transplant registry study

46. The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

47. Serum levels of polychlorinated biphenyls and risk of non-Hodgkin lymphoma: A hospital-based case-control study

48. Correlation between 18F-FDG PET-CT metrics and the pathological response in esophageal cancer treated with induction chemotherapy followed by neoadjuvant chemoradiotherapy: conventional and radiomic features

Catalog

Books, media, physical & digital resources